Summary
69 / 100 · Bulios Score
What speaks for it
- Out of every 100 JPY of revenue, 9.9 JPY is left as net profit.
- You pay 6.8 JPY for 1 JPY of yearly profit, little for its sector.
- It bought back its own shares for ¥14.4B in the last fiscal year, 5.1% of its market value.
- It has raised its dividend 5 years in a row and pays out only 36% of profit.
What to watch
- Earnings per share fell by 6.0% a year over the last 3 years.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 6.8 JPY for 1 JPY of yearly profit. Over the last five years it was 13.7 JPY on average.
Valuation in detailIs it growing?
SlowlyRevenue (JPY)
Diluted EPS (JPY)
- Analyst estimate
Revenue grew by 5.5% a year over 5 years. Over the last 3 years it grew by 5.2% a year. For the next fiscal year analysts expect revenue to fall by 2.1%. Earnings per share fell by 6.0% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 JPY of revenue goes
- Cost of sales 70 JPY
- Sales and administration 20 JPY
- Taxes and other -0.5 JPY
- Net profit 9.9 JPY
Net profit, industry median (Chemicals - Specialty) 6.0 JPY
Out of every 100 JPY of revenue, 9.9 JPY is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenIts debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 5.34%
- Paid out of profit
- 36%
- Raised in a row
- 5 years
You receive $0.50 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.